UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
Clinical trial NCT07648225 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07648225
- Sponsor
- The United Bio-Technology (Hengqin) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-31
- Primary completion
- 2027-09-29
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.